Dennis O Adeegbe

Biography

Dr. Adeegbe received his bachelors degree at Florida A&M University. He completed his graduate education in the department of Microbiology & Immunology at the Miller School of Medicine, University of Miami, where he obtained his PhD. In continuation of his research interests in autoimmunity and transplantation tolerance, he joined the Diabetes Research Institute Foundation, an affiliate research center within the medical school as a postdoctoral fellow where he focused on cellular mechanisms to promote tolerance to allografts. He continued his postdoctoral fellowship in the lab of world-renowned immunologist, Shimon Sakaguchi (Japan) where he is currently finishing his fellowship in preparation for a scientific career in the field of autoimmunity, transplantation tolerance, and tumor immunobiology. His current research revolves around elucidating the mechanisms of Treg cell-mediated tolerance both in the context of self and tumor-associated antigens, the latter being important for designing effective therapeutic modalities to augment anti-tumor immunity. Dr. Adeegbe received his bachelors degree at Florida A&M University. He completed his graduate education in the department of Microbiology & Immunology at the Miller School of Medicine, University of Miami, where he obtained his PhD. In continuation of his research interests in autoimmunity and transplantation tolerance, he joined the Diabetes Research Institute Foundation, an affiliate research center within the medical school as a postdoctoral fellow where he focused on cellular mechanisms to promote tolerance to allografts. He continued his postdoctoral fellowship in the lab of world-renowned immunologist, Shimon Sakaguchi (Japan) where he is currently finishing his fellowship in preparation for a scientific career in the field of autoimmunity, transplantation tolerance, and tumor immunobiology. His current research revolves around elucidating the mechanisms of Treg cell-mediated tolerance both in the context of self and tumor-associated antigens, the latter being important for designing effective therapeutic modalities to augment anti-tumor immunity.

Research Interest

 Autoimmunity, transplantation, cancer immunity.